表紙
市場調查報告書

整形外科用生醫材料的中國市場 (2020-2026年):移植骨替代物、玻尿酸關節內補充藥、成長因素 - MedSuite

Orthopedic Biomaterials Market Report Suite | China | 2020-2026 | Medsuite

出版商 iData Research Inc. 商品編碼 928406
出版日期 內容資訊 英文 131 Pages
商品交期: 最快1-2個工作天內
價格
整形外科用生醫材料的中國市場 (2020-2026年):移植骨替代物、玻尿酸關節內補充藥、成長因素 - MedSuite Orthopedic Biomaterials Market Report Suite | China | 2020-2026 | Medsuite
出版日期: 2020年03月01日內容資訊: 英文 131 Pages
簡介

本報告提供中國的整形外科用生醫材料市場相關調查,市場趨勢,手術數量,各產品市場區隔市場上概況、成長促進因素、阻礙成長的要素、競爭情形等系統性資訊。

目錄

圖表

摘要整理

  • 中國的整形外科用生醫材料市場市場概要
  • 競爭分析
  • 市場趨勢
  • 主要市場開發
  • 對象手術
  • 對象市場
  • 主要報告的更新
  • 版本履歷

歐洲的神經調節,神經血管及神經外科設備市場概要

競爭分析

市場趨勢

市場開發

對象手術

對象市場

主要報告的更新

版本履歷

調查方法

  • 調查範圍
  • IDATA的9等級的調查手法
  • 階段1:計劃的開始和隊伍的選擇
  • 階段2:數據系統的準備及2次調查的實施
  • 階段3:採訪的準備及問卷調查的設計
  • 階段4: 1次調查的實施
  • 階段5: 調查分析 - 基準估計的確立
  • 階段6:市場預測及分析
  • 階段7:策略性尋找機會
  • 階段8:最後檢討及市場公佈
  • 階段9:客戶回饋及市場監測

中國的整形外科生物材料市場市場概要

  • 簡介
    • 移植骨替代物
    • 玻尿酸關節內補充藥
    • 成長因素
  • 匯率
  • 市場概要
  • 趨勢分析
  • 促進市場成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析
  • 合併和收購

治療數量

  • 骨移植片替代物的治療數量
    • 各材料
    • 各適應症
  • 玻尿酸關節內補充藥的治療數量
    • 各注射循環
  • 整形外科用成長因素的治療數量
    • 治療數量

移植骨替代物市場

  • 簡介
  • 市場概要
    • 各材料
    • 各適應症
  • 市場分析、預測
    • 市場全體
    • 各材料
    • 各適應症
  • 促進成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析

玻尿酸關節內補充藥市場

  • 簡介
  • 市場概要
    • 各注射循環
  • 市場分析、預測
    • 市場全體
    • 各注射循環
  • 促進成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析

整形外科用成長因素市場

  • 簡介
  • 市場分析、預測
    • 整形外科用成長因素市場
  • 促進成長要素與阻礙因素
    • 促進因素
    • 阻礙因素
  • 競爭分析

附錄:國內競爭企業名錄

簡稱

目錄
Product Code: iDATA_CHOB20_MS

The China orthopedic biomaterials market was valued at $460.7 million in 2019. This is expected to increase over the forecast period at a CAGR of 6% to reach $690.8 million.

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 12% of the Chinese population was aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.

In the past, lower tier hospitals (I and II) were primarily served by local manufacturers with relatively simple products at significantly lower prices than the products purchased by tier III hospitals, which were primarily supplied by international companies. Now, with the financial and regulatory support of the government, increasingly difficult entry barriers for international products and weak intellectual property protection that incentivizes product plagiarism, the market has shifted in favor of local manufacturers.

The full report suite on the Chinese market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. This report also includes orthopedic growth factors and hyaluronic acid (HA) viscosupplementation.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
  • 1.2. COMPETITIVE ANALYSIS
  • 1.3. MARKET TRENDS
  • 1.4. KEY MARKET DEVELOPMENTS
  • 1.5. PROCEDURE NUMBERS
  • 1.6. MARKETS INCLUDED
  • 1.7. KEY REPORT UPDATES
  • 1.8. VERSION HISTORY

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

  • 3.1. INTRODUCTION
    • 3.1.1. Bone Graft Substitutes
    • 3.1.2. Hyaluronic Acid Viscosupplementation
    • 3.1.3. Growth Factors
  • 3.2. CURRENCY EXCHANGE RATES
  • 3.3. MARKET OVERVIEW
  • 3.4. TREND ANALYSIS
  • 3.5. DRIVERS AND LIMITERS
    • 3.5.1. Market Drivers
    • 3.5.2. Market Limiters
  • 3.6. COMPETITIVE ANALYSIS
  • 3.7. MERGERS AND ACQUISITIONS

PROCEDURE NUMBERS

  • 4.1. BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
    • 4.1.1. Bone Graft Substitute Procedure Numbers by Material
    • 4.1.2. Bone Graft Substitute Procedure Numbers by Indication
      • 4.1.2.1. Bone Graft Substitute Units per Procedure by Indication
  • 4.2. HYALURONIC ACID VISCOSUPPLEMENTATION PROCEDURE NUMBERS
    • 4.2.1. Hyaluronic Acid Viscosupplementation Procedure Numbers by Injection Cycle
  • 4.3. ORTHOPEDIC GROWTH FACTOR PROCEDURE NUMBERS
    • 4.3.1. Orthopedic Growth Factor Procedure Numbers

BONE GRAFT SUBSTITUTE MARKET

  • 5.1. INTRODUCTION
  • 5.2. MARKET OVERVIEW
    • 5.2.1. Bone Graft Substitute Market by Material
    • 5.2.2. Bone Graft Substitute Market by Indication
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Total Bone Graft Substitute Market
    • 5.3.2. Total Bone Graft Substitute Market by Material
      • 5.3.2.1. Allograft Bone Graft Substitute Market
      • 5.3.2.2. Demineralized Bone Matrix Market
      • 5.3.2.3. Synthetic Bone Graft Substitute Market
    • 5.3.3. Total Bone Graft Substitute Market by Indication
      • 5.3.3.1. Total Spine Market
      • 5.3.3.1.1. Cervical Spine Market
      • 5.3.3.1.2. Thoracolumbar Spine Market
      • 5.3.3.2. Trauma & Reconstruction Market
      • 5.3.3.3. Bone Tumor Market
      • 5.3.3.4. CMF Market
  • 5.4. DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET OVERVIEW
    • 6.2.1. Hyaluronic Acid Viscosupplementation Market by Injection Cycle
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Total Hyaluronic Acid Viscosupplementation Market
    • 6.3.2. Total Hyaluronic Acid Viscosupplementation Market by Injection Cycle
      • 6.3.2.1. Single-Injection Hyaluronic Acid Viscosupplementation Market
      • 6.3.2.2. Three-Injection Hyaluronic Acid Viscosupplementation Market
      • 6.3.2.3. Five-Injection Hyaluronic Acid Viscosupplementation Market
  • 6.4. DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE ANALYSIS

ORTHOPEDIC GROWTH FACTOR MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET ANALYSIS AND FORECAST
    • 7.2.1. Orthopedic Growth Factor Market
  • 7.3. DRIVERS AND LIMITERS
    • 7.3.1. Market Drivers
    • 7.3.2. Market Limiters
  • 7.4. COMPETITIVE ANALYSIS

APPENDIX: LOCAL COMPETITOR DIRECTORY

  • 8.1. WEBSITE DIRECTORY

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022
  • Chart 1 2: Orthopedic Biomaterials Market Overview, China, 2015 & 2022
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, China, 2015
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, China, 2022
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, China, 2012 - 2022
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, China, 2015
  • Chart 4 1: Bone Graft Substitute Procedures by Material, China, 2012 - 2022
  • Chart 4 2: Bone Graft Substitute Procedures by Indication, China, 2012 - 2022
  • Chart 4 3: Total Bone Graft Substitute Units Sold per Procedure by Indication (Excluding Autograft), China, 2012 - 2022
  • Chart 4 4: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, China, 2012 - 2022
  • Chart 4 5: Orthopedic Growth Factor Procedures, China, 2012 - 2022
  • Chart 5 1: Bone Graft Substitute Market by Material, China, 2012 - 2022
  • Chart 5 2: Bone Graft Substitute Market Breakdown by Material, China, 2015
  • Chart 5 3: Bone Graft Substitute Market Breakdown by Material, China, 2022
  • Chart 5 4: Bone Graft Substitute Market by Indication, China, 2012 - 2022
  • Chart 5 5: Bone Graft Substitute Market Breakdown by Indication, China, 2015
  • Chart 5 6: Bone Graft Substitute Market Breakdown by Indication, China, 2022
  • Chart 5 7: Total Bone Graft Substitute Market, China, 2012 - 2022
  • Chart 5 8: Allograft Bone Graft Substitute Market, China, 2012 - 2022
  • Chart 5 9: Demineralized Bone Matrix Market, China, 2012 - 2022
  • Chart 5 10: Synthetic Bone Graft Substitute Market, China, 2012 - 2022
  • Chart 5 11: Total Spine Market, China, 2012 - 2022
  • Chart 5 12: Cervical Spine Market, China, 2012 - 2022
  • Chart 5 13: Thoracolumbar Spine Market, China, 2012 - 2022
  • Chart 5 14: Trauma & Reconstruction Market, China, 2012 - 2022
  • Chart 5 15: Bone Tumor Market, China, 2012 - 2022
  • Chart 5 16: Bone Tumor Market, China, 2012 - 2022
  • Chart 5 17: Leading Competitors, Bone Graft Substitute Market, China, 2015
  • Chart 6 1: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 - 2022
  • Chart 6 2: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2015
  • Chart 6 3: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2022
  • Chart 6 4: Total Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022
  • Chart 6 5: Three-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022
  • Chart 6 6: Five-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022
  • Chart 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2015
  • Chart 7 1: Orthopedic Growth Factor Market, China, 2012 - 2022
  • Chart 7 2: Leading Competitors, Orthopedic Growth Factor Market, China, 2015

LIST OF FIGURES

  • Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, China, 2015
  • Figure 1 2: Companies Researched in this Report, China, 2015
  • Figure 1 3: Factors Impacting the Orthopedic Biomaterials Market by Segment, China
  • Figure 1 4: Recent Events in the Orthopedic Biomaterials Market, China, 2012 - 2015
  • Figure 1 5: Orthopedic Biomaterials Procedures Covered, China, 2015
  • Figure 1 6: Orthopedic Biomaterials Markets Covered, China, 2015
  • Figure 1 7: Key Report Updates, China, 2013 & 2016
  • Figure 1 8: Version History
  • Figure 3 1: Currency Exchange Rates, 2015
  • Figure 3 2: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022 (US$M)
  • Figure 3 3: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022 (CN¥M)
  • Figure 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, China, 2012 - 2022
  • Figure 3 5: Drivers and Limiters, Orthopedic Biomaterials Market, China, 2015
  • Figure 3 6: Leading Competitors, Orthopedic Biomaterials Market, China, 2015
  • Figure 4 1: Bone Graft Substitute Procedures by Material, China, 2012 - 2022
  • Figure 4 2: Bone Graft Substitute Procedures (Excluding Autograft Procedures) by Indication, China, 2012 - 2022
  • Figure 4 3: Total Bone Graft Substitute Units Sold by Indication (Excluding Autograft), China, 2012 - 2022 (10cc)
  • Figure 4 4: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, China, 2012 - 2022
  • Figure 4 5: Orthopedic Growth Factor Procedures, China, 2012 - 2022
  • Figure 5 1: Bone Graft Substitute Market by Material, China, 2012 - 2022 (US$M)
  • Figure 5 2: Bone Graft Substitute Market by Material, China, 2012 - 2022 (CN¥M)
  • Figure 5 3: Bone Graft Substitute Market by Indication, China, 2012 - 2022 (US$M)
  • Figure 5 4: Bone Graft Substitute Market by Indication, China, 2012 - 2022 (CN¥M)
  • Figure 5 5: Total Bone Graft Substitute Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 6: Allograft Bone Graft Substitute Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 7: Demineralized Bone Matrix Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 8: Synthetic Bone Graft Substitute Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 9: Total Spine Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 10: Cervical Spine Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 11: Thoracolumbar Spine Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 12: Trauma & Reconstruction Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 13: Bone Tumor Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 14: CMF Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 15: Drivers and Limiters, Bone Graft Substitute Market, China, 2015
  • Figure 5 16: Leading Competitors, Bone Graft Substitute Market, China, 2015
  • Figure 6 1: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 - 2022 (US$M)
  • Figure 6 2: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 - 2022 (CN¥M)
  • Figure 6 3: Total Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 6 4: Three-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 6 5: Five-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 6 6: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, China, 2015
  • Figure 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2015
  • Figure 7 1: Orthopedic Growth Factor Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 7 2: Drivers and Limiters, Orthopedic Growth Factor Market, China, 2015
  • Figure 7 3: Leading Competitors, Orthopedic Growth Factor Market, China, 2015